Past Pfizer executive Keith O’Briant — now CEO of Lacerta Life Sciences — saw the “remarkable” benefits that its Lacertamatrix Hyaluronic Acid Foam Dressing had on patients with severely compromised skin.

Feeling a “moral obligation” to capitalize on the benefits of hyaluronic acid used in this capacity, he sought to find his own company, Hydrinity Accelerated Skin Science. On this Happi Podcast, O’Briant discusses its role in wound healing and the story behind the company’s name, which means “hydration to the power of infinity.”